Application of contrast-enhanced ultrasound in the diagnosis of urinary tumors

doi:10.3877/cma.j.issn.2095-3216.2018.05.007

Abstract

Abstract:

Ultrasonography is a non-invasive examination technology, and has become a commonly used auxiliary examination method for urinary tumors. Especially, the application and development of contrast-enhanced ultrasound technology can provide valuable imaging information for early diagnosis and treatment of urinary tumors. This review was a summary of the application of contrast-enhanced ultrasound for urological tumors.

Key words: Contrast-enhanced ultrasound (CEUS), Urinary tumor, Differential diagnosis

Qiuyang Li, Nan Li, Yiru Wang, Yukun Luo, Jie Tang. Application of contrast-enhanced ultrasound in the diagnosis of urinary tumors[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2018, 07(05): 220-223.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2018.05.007

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2018/V07/I05/220

References 50

[1]	《肾细胞癌诊断治疗指南》编写组. 肾细胞癌诊断治疗指南(2008年第一版)[J]. 中华泌尿外科杂志，2009, 30(1)：63-69.
[2]	Cosgrove D. Ultrasound contrast agent: an overview [J]. Eur J Radilo, 2006, 60(3): 324-330.
[3]	Quaia E, Alaimo V, Baratella E, et al. Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection [J]. J Ultrasound Med, 2010, 29(1): 25-36.
[4]	Jang HJ, Yu H, Kim TK. Contrast-enhanced ultrasound in the detection and characterization of liver tumors [J]. Cancer Imaging, 2009, 9(11): 96-103.
[5]	Caruso G, Salvaggio G, Campisi A, et al. Bladder tumor stating: comparison of contrast-enhanced and gray-scale ultrasound [J]. Am J Roentgenol, 2010, 194(1): 151-156.
[6]	Correas JM, Bridal L, Lesavre A, et al. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts [J]. Eur Radiol, 2001, 11(8): 1316-1328.
[7]	Gorce JM, Arditi M, Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: a study of SonoVue [J]. Invest Radiol, 2000, 35(11): 661-671.
[8]	Sun Y, Kruse DE, Ferrara KW. Contrast imaging with chirped excitation [J]. IEEE Trans Ultrason Ferroelectr Freq Control, 2007, 54(3): 520-529.
[9]	Schwarz KQ, Chen X, Bezante GP, et al. The Doppler kinetics of microbubble echo contrast [J]. Ultrasound Med Biol, 1996, 22(4): 453-462.
[10]	Quaia E. Contrast media in ultrasonography: basic principles and clinical applications [M]. Berlin Heidelberg: Springer-Verlag, 2005.
[11]	Siracusano S, Beortolotto M, Ciciliato S, et al. The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology [J]. World J Urol, 2011, 29(5): 633-638.
[12]	Ebele JN, Sauter G, Epstein JI, et al. Pathology and genetics of tumors of the urinary system and male genital organs [M]. London: Oxford University Press, 2004.
[13]	Li X, Liang P, Guo M, et al. Real-time contrast-enhanced ultrasound in diagnosis of solid renal lesions [J]. Discov Med, 2013, 16(86): 15-25.
[14]	Ignee A, Straub B, Brix D, et al. The value of contrast enhanced ultrasound (CEUS) in the characterization of patients with renal masses [J]. Clin Hemorheol Microcirc, 2010, 46(4): 275-290.
[15]	Pichler R, Heidegger I, Aigner F, et al. De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound [J]. Urol Int, 2014, 93(3): 364-367.
[16]	May M, Fiearra V, Shariat SF, et al. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting dect renal cell carcinoma: development of a disease specific risk mode [J]. J Urol, 2013, 190(2): 458-463.
[17]	Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system [J]. Urology, 2005, 66(3): 484-488.
[18]	王金锐，苗立英，崔立刚，等. 超声造影在囊性肾病变中的应用价值[J]. 中国医学科学院学报，2008, 30(1)：22-26.
[19]	Terada N, Aral Y, Kinukawa N, et al. The 10-year natural history of simple renal cyst [J]. Urology, 2008, 71(1): 7-11.
[20]	Park BK, Kim B, Kim SH, et al. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US [J]. Eur J Radiol, 2007, 61(2): 310-314.
[21]	Xu ZF, Xu HX, Xie XY, et al. Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography [J]. J Ultrsound Med, 2010, 29(5): 709-717.
[22]	Quaia E, Siracusano S, Bertolotto M, et al. Characterization of renal tumors with pulse inversion harmonic imaging by intermittent high mechanical index technique preliminary results [J]. Eur Radiol, 2003, 13(6): 1402-1412.
[23]	周翔，张艳容，项飞翔，等. 肾脏错构瘤超声造影动态特性分析[J]. 华中科技大学学报(医学版), 2006, 35(5)：689-691.
[24]	Tato Rodreguez J, Lema Grille J, Cimadevila Garcia A, et al. A fibroepithelial polyp of the ureter: a report of 2 new cases [J]. Actas Urol Esp, 1997, 21(4): 420-425.
[25]	Patschan O, Horstmann M, Thomas C, et al. Diagnostic procedures in upper urinary tract urothelial carcinoma [J]. Urology, 2008, 47(11): 1487-1496.
[26]	李秋洋，何恩辉，周昀，等. 超声造影在输尿管肿瘤诊断中的临床应用研究[J]. 微创泌尿外科杂志，2016，5(5)：303-305.
[27]	Drudi FM, Di Candio G, Di Leo N, et al. Contrast-enhanced ultrasonography in the diagnosis of upper urinary tract urothelial cell carcinoma: a preliminary study [J]. Ultraschall Med, 2013, 34(1): 30-37.
[28]	Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006 [J]. CA Cancer J Clin, 2006, 56(2): 106-130.
[29]	Edge S, Byrd DR, Compton CC, et al. AJCC cancer staging handbook [M]. 7th ed. New York: Springer-Verlag, 2002.
[30]	Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder [J]. Eur Urol, 2008, 54(2): 303-314.
[31]	Stenzl A, Cowan NC, De Santis M, et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer [J]. Eur Urol, 2009, 55(4): 815-825.
[32]	Kim JK, Park SY, Ahn HJ, et al. Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging [J]. Radiology, 2004, 231(3): 725-731.
[33]	Francica G, Bellini SA, Scarano F, et al. Correlation of transabdominal sonographic and cystoscopic findings in the diagnosis of focal abnormalities of the urinary bladder wall: a prospective study [J]. J Ultrasound Med, 2008, 27(6): 887-894.
[34]	Caruso G, Salvaggio G, Campisi A, et al. Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound [J]. AJR Am J Roentgenol, 2010, 194(1): 151-156.
[35]	李秋洋，唐杰，何恩辉，等. 三维超声造影在膀胱肿瘤分期中的应用价值[J/CD]. 中华医学超声杂志(电子版), 2012，9(2)：56-59.
[36]	Li Q, Tang J, He E, et al. Clinical utility of three-dimensional contrast-enhanced ultrasound in the differentiation between noninvasive and invasive neoplasms of urinary bladder [J]. Eur J Radiol, 2012, 81(11): 2936-2942.
[37]	Ebele JN, Sauter G, Epstein JI, et al. Pathology and genetics of tumors of the urinary system and male genital organs [M]. London: Oxford University Press, 2004.
[38]	Li Q, Tang J, He E. Differentiation of high and low grade urothelial carcinoma using contrast-enhanced ultrasound: Retrospective and prospective studies [J]. Oncotarget, 2017, 41(8): 70883-70889.
[39]	李秋洋，唐杰，何恩辉，等. 超声造影在鉴别膀胱肿瘤分级中的应用价值[J]. 中国医学科学院学报，2012，34(4)：329-333.
[40]	Gunelli R, Fiori M, Bercovich E. Imaging of the prostate: traditional methods [J]. Arch Ital Urol Androl, 2002, 74(4): 177-181.
[41]	Kay PA, Robb RA, Bostwick DG. Prostate cancer microvessels: a novel method for three-dimensional reconstruction and analysis [J]. Prostate, 1998, 37(4): 270-277.
[42]	Louvar E, Littrup PJ, Goldstein A, et al. Correlation of color Doppler flow in the prostate with tissue microvascularity [J]. Cancer, 1998, 83(1): 135-140.
[43]	Halpern EJ, McCue PA, Aksnes AK, et al. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients [J]. Radiology, 2002, 222(2): 361-366.
[44]	Halpern EJ, Verkh L, Forsberg F, et al. Initial experience with contrast-enhanced sonography of the prostate [J]. Am J Roentgenol, 2000, 174(6): 1575-1580.
[45]	Li Y, Tang J, Fei X, et al. Diagnostic performance of contrast enhanced ultrasound in patients with prostate cancer: a meta-analysis [J]. Acad Radiol, 2013, 20(2): 156-164.
[46]	Sidhu PS, Cantisan V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017[J]. Ultraschall Med, 2018, 39(2): 154-180.
[47]	Yunkai Z, Yaqing C, Jun J, et al. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection; results of a prospective cohort study with 1024 patients [J]. World J Urol, 2018, [Epub ahead of print].
[48]	Rossi SH, Prezzi D, Kelly-Morland C, et al. Imaging for the diagnosis and response assessment of renal tumors [J]. World J Urol, 2018, [Epub ahead of print].
[49]	Stock K, Kubler H, Maurer T, et al. Innovative ultrasound: contrast-enhanced ultrasound of the kidneys [J]. Aktuelle Urol, 2017, 48(2): 120-126.
[50]	Chong WK, Papadopoulou V, Dayton PA. Imaging with ultrasound contrast agent: current status and future [J]. Abdom Radiol(NY), 2018, 43(4): 762-772.

Please choose a citation manager

Content to export